J.D. Power and Associates Commissioned for Inaugural Health Care Information Technology Study

Article

KANSAS CITY, Mo., Feb. 10 /PRNewswire-FirstCall/ -- In this climate of intense corporate scrutiny, do trust and transparency matter in the health care information technology (HCIT) buying equation? J.D. Power and Associates, as commissioned by Cerner

KANSAS CITY, Mo., Feb. 10 /PRNewswire-FirstCall/ -- In this climate of intense corporate scrutiny, do trust and transparency matter in the health care information technology (HCIT) buying equation? J.D. Power and Associates, as commissioned by Cerner Corporation , has conducted a study among health care executives to better understand the importance of disclosing key corporate measures that demonstrate suppliers' capabilities and commitment to HCIT.

Study results will be revealed at a presentation Monday, February 10 at 2:00 p.m. Pacific Standard Time at the 2003 HIMSS conference in San Diego in Media room 14B of the San Diego Convention Center. Steven Wood, executive director for the health care division of J. D. Power and Associates and Neal Patterson, chairman and chief executive officer of Cerner Corporation will be explaining the significance of these important findings.

J.D. Power and Associates is the authoritative voice on client satisfaction. Each year, the firm conducts studies in more than 60 countries to better understand clients' opinions and expectations regarding the products and services they purchase. The firm's studies have become industry benchmarks for measuring quality and client satisfaction in many industries worldwide. This is the first HCIT study conducted by J.D. Power and Associates, and is critical in its timing because of the increasing acceptance of HCIT as a key strategy to address the major issues within health care today, and the growing need for a more full disclosure by HCIT suppliers.

J.D. Power and Associates has posed a set of questions to health care executives on the importance of full disclosure, and HCIT suppliers were surveyed on seven top criteria for trust. These criteria include:

-- Disclose annual revenues -- Disclose annual research and development on modern solutions -- Disclose rollout status of modern solutions -- Demonstrate solutions on live code -- Vouch for the veracity of all public statements -- Disclose human resource allocations -- Disclose conversions

"The American health care system is in crisis. Technology is a key solution," said Neal Patterson, chairman and chief executive officer for Cerner Corporation. "If we are to make an effective case to health care executives and national policy makers, our industry must hold itself to a higher standard."

Cerner Corporation is the leading supplier of clinical and management information and knowledge systems to more than 1,500 health care organizations worldwide. Cerner is working to transform the health care delivery system by increasing the quality of care, improving efficiencies, eliminating medical error and connecting the individual to the system with innovative information solutions. The following are trademarks of Cerner: Cerner, and Cerner's logo. Nasdaq: CERN, http://www.cerner.com/

Cerner Corporation

CONTACT: Media, Jessica Weeks, +1-816-201-5114, jweeks@cerner.com , or
Investors, Allan Kells, +1-816-201-2445, akells@cerner.com , both of Cerner
Corporation

Web site: http://www.cerner.com/

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.